Survivorship Documentation That Actually Travels Between Clinicians
A treatment summary is only useful if the next clinician can find it in under a minute. Structuring exposures, surveillance owners and intervals so the record survives every handoff.
Most survivorship documentation fails at the same point: the next clinician cannot find it. The treatment summary exists, somewhere, as scanned correspondence in a records system nobody searches during a fifteen-minute visit. Documentation that travels is structured for retrieval, not for completeness.
The one-minute retrieval test
If a clinician who has never met the patient cannot locate treatment exposures and the current surveillance plan within about a minute, the documentation will not influence care. Apply that as the acceptance criterion for any template.
This favours a short structured block in a consistently located field over a long narrative letter, however complete the letter is.
The minimum structured fields
Diagnosis with date; agents received with cumulative anthracycline dose where relevant; radiation fields, dose and dates; surgical history; relevant transplant or cellular-therapy details; ongoing endocrine or maintenance therapy.
Then the forward-looking half: identified late-effect risks, each surveillance item with interval, the named owner of each item, the next due date, and the date this record was last reviewed.
Name owners, not specialties
"Cardiology will monitor" produces gaps at every transition. A named clinician or an explicitly defined role with a documented next date survives staff changes; a specialty label does not.
Where care is shared, the record should also state who is responsible for reordering surveillance if the patient does not attend.
Give the patient a copy that stands alone
The patient is the only participant present at every future visit, including in systems that cannot exchange records. A portable copy — printed or exportable — is the most reliable interoperability mechanism available.
That copy should be readable without clinical training: what was received, what is being watched, how often, who orders it, and which symptoms warrant contact before the next appointment.
Review dates and change history
A survivorship plan without a review date silently becomes historical. Record when it was last reviewed and against which guideline version, so that when society guidance updates, affected patients can be identified rather than rediscovered individually.
This is also what makes documentation auditable: you can answer how many high-risk survivors have an overdue surveillance item, which is the question that actually drives improvement.
Frequently asked questions
- Is a treatment summary enough on its own?
- No. A summary describes the past; a usable survivorship record also carries the surveillance schedule, intervals, named owners and next due dates.
- Who should own updating the record?
- Whichever clinician holds the longitudinal relationship, most often primary care after handoff, provided the record names that owner explicitly and carries a review date.